Search
R1295
go.drugbank.com/drugs/DB05122ExperimentalR1295 is an integrin antagonist currently in clinical trials for the treatment of rheumatoid arthritis.
Capric acid
go.drugbank.com/drugs/DB03600InvestigationalThe proteins that decanoic acid targets include furin, octanoyltransferase, 3-oxoacyl-[acyl-carrier-protein] synthase 1, peptostreptococcal albumin-binding protein, and putative uncharacterized protein
Myrcludex B
go.drugbank.com/drugs/DB14853InvestigationalMyrcludex B is under investigation in clinical trial NCT03546621 (A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination
Vicasinabin
go.drugbank.com/drugs/DB21587InvestigationalVicasinabin is under investigation in clinical trial NCT04265261 (A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic
Risuteganib
go.drugbank.com/drugs/DB14911InvestigationalRisuteganib is under investigation in clinical trial NCT02348918 (Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema).
Categories: Amino Acids, Peptides, and ProteinsApraglutide
go.drugbank.com/drugs/DB18084InvestigationalCategories: Amino Acids, Peptides, and ProteinsPegtarazimod
go.drugbank.com/drugs/DB19318ExperimentalCategories: Amino Acids, Peptides, and Proteins7-Keto-8-Aminopelargonic Acid
go.drugbank.com/drugs/DB02274ExperimentalCategories: Amino Acids, Peptides, and Proteins